KAREN JOHNSON: Open Payments
NPI 1417090523 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$720 in 36 payments from 10 companies in 2025. Trend: 2023 $823 · 2024 $936 · 2025 $720
Food & beverage: $720
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $235 |
| PFIZER INC. | 5 | $91 |
| ABBVIE INC. | 4 | $82 |
| GlaxoSmithKline, LLC. | 3 | $76 |
| Lilly USA, LLC | 3 | $62 |
| Amgen Inc. | 3 | $55 |
| Abbott Laboratories | 2 | $40 |
| Exact Sciences Corporation | 1 | $28 |
| Novo Nordisk Inc | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
Products named: AIRSUPRA, FARXIGA, NURTEC ODT, TRELEGY ELLIPTA, QULIPTA, MOUNJARO, OTEZLA, The Cologuard Plus Collection Kit.
Industry payments across FL — which companies pay providers there.
